# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-25-014057
Filing Date
2025-09-18
Accepted
2025-09-18 16:05:46
Documents
19
Period of Report
2025-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8-k.htm iXBRL | 8-K | 40356
2 | EX-10.1 | ex10-1.htm | EX-10.1 | 4199
3 | GRAPHIC | ex10-1_001.jpg | GRAPHIC | 659617
4 | GRAPHIC | ex10-1_002.jpg | GRAPHIC | 1091579
5 | GRAPHIC | ex10-1_003.jpg | GRAPHIC | 1036459
6 | GRAPHIC | ex10-1_004.jpg | GRAPHIC | 1126161
7 | GRAPHIC | ex10-1_005.jpg | GRAPHIC | 843293
8 | GRAPHIC | ex10-1_006.jpg | GRAPHIC | 122973
| Complete submission text file | 0001493152-25-014057.txt |  | 6933971

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | prph-20250918.xsd | EX-101.SCH | 3026
10 | XBRL LABEL FILE | prph-20250918_lab.xml | EX-101.LAB | 34239
11 | XBRL PRESENTATION FILE | prph-20250918_pre.xml | EX-101.PRE | 22366
21 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3716

Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

EIN.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 251323485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)